Volume 15, Issue 1, Pages (January 2012)

Slides:



Advertisements
Similar presentations
Ultra long term outcomes in adult survivors of tetralogy of Fallot and the effect of pulmonary valve replacement Dobson R1,2, Danton M2, Walker N2, Tzemos,
Advertisements

Congestive heart failure: Treat the disease, not the symptom—Return to normalcy  Gerald D. Buckberg, MD  The Journal of Thoracic and Cardiovascular Surgery 
Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.
Anna Hallbergson, MD, PhD, Kimberlee Gauvreau, ScD, Andrew J
Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: Implications for timing.
Valve-Sparing Aortic Root Replacement
Left ventricular dysfunction after mitral valve repair—the fallacy of “normal” preoperative myocardial function  Eduard Quintana, MD, Rakesh M. Suri,
James S. Tweddell, MD, Michael G. Earing, MD, Peter J
The STICH trial: Misguided conclusions
Pulmonary Valve Preservation Strategies for Tetralogy of Fallot Repair
Analysis of risk factors for recurrence after video-assisted pulmonary vein isolation of lone atrial fibrillation—results of 5 years of follow-up  Qiu-Ming.
Valve-sparing repair to alleviate pulmonary regurgitation may lead to as much right ventricular dilatation as a transannular patch: A catch-22?  Tae-Jin.
Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,
Ross operation: 16-year experience
Valve-Sparing Options in Tetralogy of Fallot Surgery
C. Wesley Lindsey, MD, W. James Parks, MD, Brian E
Using contracting band to improve right ventricle ejection fraction for patients with repaired tetralogy of Fallot: A modeling study using patient-specific.
Anthony P. Furnary, MDa, Juan-Carlos Chachques, MD, PhDb, Luiz F. P
Long-term results of heart valve replacement with the Edwards Duromedics bileaflet prosthesis: A prospective ten-year clinical follow-up  Bruno K. Podesser,
Factors influencing early and late outcome of the arterial switch operation for transposition of the great arteries  Gil Wernovsky, MD* (by invitation),
Mechanical stress is associated with right ventricular response to pulmonary valve replacement in patients with repaired tetralogy of Fallot  Dalin Tang,
Prolonged QTc affects short-term and long-term outcomes in patients with normal left ventricular function undergoing cardiac surgery  Nattachai Anantasit,
Does limited right ventriculotomy prevent right ventricular dilatation and dysfunction in patients who undergo transannular repair of tetralogy of Fallot?
Surgical therapy for ischemic heart failure: Single-center experience with surgical anterior ventricular restoration  Lorenzo Menicanti, MD, Serenella.
Pulmonary hypertension in valve disease: A beast of the past?
Jonathan W. Cramer, MD, Salil Ginde, MD, Garick D. Hill, MD, Scott B
Volume 15, Issue 1, Pages (January 2012)
The Relentless Effects of the Fontan Paradox
Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.
Benefits of Early Surgery on Clinical Outcomes After Degenerative Mitral Valve Repair  Tianyu Zhou, MD, Jun Li, MD, PhD, Hao Lai, MD, PhD, Kai Zhu, MD,
Ebstein's Anomaly of the Tricuspid Valve: The Cone Repair
Aggressive Patch Augmentation May Reduce Growth Potential of Hypoplastic Branch Pulmonary Arteries After Tetralogy of Fallot Repair  Travis J. Wilder,
Mechanical valves versus the Ross procedure for aortic valve replacement in children: Propensity-adjusted comparison of long-term outcomes  Bahaaldin.
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
Impact of Preoperative Symptoms on Postoperative Survival in Severe Aortic Stenosis: Implications for the Timing of Surgery  Sophie Piérard, MD, Christophe.
Mitral valve operation in patients with the Marfan syndrome
Congestive heart failure: Treat the disease, not the symptom—Return to normalcy  Gerald D. Buckberg, MD  The Journal of Thoracic and Cardiovascular Surgery 
Volume 15, Issue 1, Pages (January 2012)
Atrioventricular valve repair in patients with functional single-ventricle physiology: Impact of ventricular and valve function and morphology on survival.
Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: Implications for future guidelines  Andrew B.
Long-term outcomes after definitive repair for tetralogy of Fallot with preservation of the pulmonary valve annulus  Takaya Hoashi, MD, PhD, Koji Kagisaki,
Work capacity and central hemodynamics thirteen to twenty-six years after repair of tetralogy of fallot  Hans Jonsson, MDa, Torbjörn Ivert, MDa, Rune.
Factors affecting late survival after surgical remodeling of left ventricular aneurysms  Hooshang Bolooki, MD, Eduardo DeMarchena, MD, Stephen M Mallon,
Aortic Valve Insufficiency: Leaflet Reconstruction Techniques
Tricuspid Valve Repair in Single Ventricle: Timing and Techniques
Vikas Sharma, MBBS, Rakesh M. Suri, MD, DPhil, Joseph A
Vladimiro L. Vida, MD, PhD, Fabio Zucchetta, MD, Giovanni Stellin, MD 
Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial  Michael A. Acker, MD,
Role of myocardial hypertrophy on acute and chronic right ventricular performance in relation to chronic volume overload in a porcine model: Relevance.
Evolving strategies for preserving the pulmonary valve during early repair of tetralogy of Fallot: Mid-term results  Vladimiro L. Vida, MD, PhD, Alvise.
Valve performance classification in 630 subcoronary Ross patients over 22 years  Hans-Hinrich Sievers, MD, Ulrich Stierle, MD, Michael Petersen, MD, Stefan.
Ivo R. Henkens, MD, Alexander van Straten, MD, Martin J
Pulmonary Homograft Monocusp Reconstruction of the Right Ventricular Outflow Tract: Outcomes to the Intermediate Term  Dilip S. Nath, MD, Daniel P. Nussbaum,
Optimal Timing for Elective Early Primary Repair of Tetralogy of Fallot: Analysis of Intermediate Term Outcomes  Michael E.A. Cunningham, MD, Mary T.
Intersurgeon variability in long-term outcomes after transatrial repair of tetralogy of Fallot: 25 years' experience with 675 patients  Yves d'Udekem,
A 26-year experience with surgical management of tetralogy of fallot: risk analysis for mortality or late reintervention  Christopher J. Knott-Craig,
The Ross procedure: Outcomes at 20 years
Long-term importance of right ventricular outflow tract patch function in patients with pulmonary regurgitation  Rajesh Puranik, MD, Victor Tsang, MD,
Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot 
Heart transplantation in patients with previous cardiac operations:
Intraoperative adverse events can be compensated by technical performance in neonates and infants after cardiac surgery: A prospective study  Meena Nathan,
Power loss and right ventricular efficiency in patients after tetralogy of Fallot repair with pulmonary insufficiency: Clinical implications  Mark A.
Reversibility of Cardiac Dysfunction After Valve Replacement in Elderly Patients With Severe Aortic Stenosis  Masafumi Natsuaki, MD, Tsuyoshi Itoh, MD,
Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement  Todd M. Dewey,
Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams  V.Mohan Reddy, MDa, Doff B. McElhinney, MDa,
Complete atrioventricular septal defect, Down syndrome, and surgical outcome: risk factors  Amira A Al-Hay, MRCP, Stephanie J MacNeill, MS, Magdi Yacoub,
Pulmonary Valve Repair for Patients With Acquired Pulmonary Valve Insufficiency  Sameh M. Said, MD, Richard D. Mainwaring, MD, Michael Ma, MD, Theresa.
Pulmonary valve cusp augmentation with autologous pericardium may improve early outcome for tetralogy of Fallot  Petros Anagnostopoulos, MD, Anthony Azakie,
Eleanor T. Ross, MD, John M. Costello, MD, MPH, Carl L
Right ventricular–pulmonary arterial coupling in patients after repair of tetralogy of Fallot  Heiner Latus, MD, Wolfhard Binder, MD, Gunter Kerst, MD,
Presentation transcript:

Volume 15, Issue 1, Pages 27-33 (January 2012) Timing and Technique of Pulmonary Valve Replacement in the Patient With Tetralogy of Fallot  James S. Tweddell, Pippa Simpson, Shun-Hwa Li, Jennifer Dunham-Ingle, Peter J. Bartz, Michael G. Earing, Andrew N. Pelech  Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual  Volume 15, Issue 1, Pages 27-33 (January 2012) DOI: 10.1053/j.pcsu.2012.01.007 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Long-term survival curve of 490 early survivors of repair of TOF. The curve shows two different phases that are distinct. The early, low-risk phase lasts 25 years; thereafter, the risk increases significantly. Mortality risk (r) per year, as a linearized number, is calculated for each phase. (Reprinted with permission.1) Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2012 15, 27-33DOI: (10.1053/j.pcsu.2012.01.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 Survival curve showing freedom from sudden death after repair of TOF comparing patients who had a transannular patch for RVOT reconstruction with those who did not during tetralogy repair. The risk of sudden death was significantly higher among patients with a transannular patch. Patients with a transannular patch would be anticipated to have significant PR. (Reprinted with permission.2) Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2012 15, 27-33DOI: (10.1053/j.pcsu.2012.01.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 Survival curves from a case control study comparing 77 patients who underwent PVR with 77 matched patients who did not undergo PVR. Survival was not improved among patients who underwent PVR. (Reprinted with permission.4) Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2012 15, 27-33DOI: (10.1053/j.pcsu.2012.01.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 4 NYHA functional class before and at last follow-up in patients undergoing PVR after TOF repair. (Reprinted with permission.6) Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2012 15, 27-33DOI: (10.1053/j.pcsu.2012.01.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 5 The impact of PVR on RV end-diastolic (A) and RV end-systolic (B) volumes as determined by CMR. Among 17 patients, baseline CMR imaging studies were performed at a mean of 10 ± 9 months before PVR and postoperative CMR imaging at a mean of 21 ± 11 months after PVR. Whereas volumes were reduced in all 17 patients after PVR those with a preoperative RV end-diastolic volume <170 mL/m2 had a late RV end-diastolic volume within the normal range and those with a preoperative RV end-systolic volume <85 mL/m2 had a late RV end-systolic volume within the normal range. Dashed horizontal line represents normal volume. (Reprinted with permission.22) Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2012 15, 27-33DOI: (10.1053/j.pcsu.2012.01.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 6 In this study, 88 patients with a median time from TOF repair of 20.7 years underwent CMR and were then followed for a median time of 4.2 years. The figure shows the probability of major adverse clinical outcomes (death, sustained ventricular tachycardia, or an increase in NYHA class to grade III or IV) based on multivariate logistic regression model containing RV end-diastolic volume (RVEDV) Z-score and RV ejection fraction (RVEF). (Reprinted with permission.24) Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2012 15, 27-33DOI: (10.1053/j.pcsu.2012.01.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 7 Surgical technique for PVR. A, A stented bioprosthetic valve is sewn into the orthotopic position in the RVOT. B, The RVOT is augmented with a patch as necessary to accommodate the valve. Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2012 15, 27-33DOI: (10.1053/j.pcsu.2012.01.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 8 Survival of patients over 5 years of age undergoing PVR for TOF and variants. There was no significant difference in survival among patients receiving a homograft compared with a heterograft. Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2012 15, 27-33DOI: (10.1053/j.pcsu.2012.01.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 9 Freedom from reintervention and death among patients over 5 years of age undergoing PVR for TOF and variants. There was no significant difference in reintervention-free survival among patients receiving a homograft compared with a heterograft. Seminars in Thoracic & Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2012 15, 27-33DOI: (10.1053/j.pcsu.2012.01.007) Copyright © 2012 Elsevier Inc. Terms and Conditions